Andrographis Paniculata: Benefits, Uses, and Side Effects

Andrographis paniculata is a bitter-tasting plant from the Acanthaceae family that has been used for centuries across Asia, Africa, and parts of the Americas to treat infections, fevers, and digestive complaints. Its main active compound, andrographolide, has genuine anti-inflammatory and immune-modulating properties backed by a growing body of clinical research, particularly for upper respiratory tract infections. But the picture is more nuanced than supplement marketing suggests, with real concerns about liver enzyme changes, drug interactions, and reproductive effects that deserve attention alongside the benefits.

What Andrographis Is and Where It Comes From

Known colloquially as “king of bitters” for its intensely unpleasant taste, Andrographis paniculata is a slender annual herb native to South and Southeast Asia. It has deep roots in Ayurvedic, Siddha, and traditional Chinese medicine, where it goes by names like kalmegh (Hindi) and chuān xīn lián (Mandarin). Traditionally, practitioners have used it for an remarkably wide range of conditions: common colds, diarrhea, fever, jaundice, liver support, and even as a contraceptive.¹ In Indian tribal medicine systems, it has historically been relied upon primarily for infectious diseases.²

The plant’s pharmacological activity comes mainly from a group of compounds called diterpene lactones, with andrographolide being the most abundant and best studied. Andrographolide content in the dried plant material varies quite a bit depending on growing conditions, plant parts used, and drying methods. Lab analyses show andrographolide content ranging from about 0.7% to over 4% of dry weight, and drying temperature matters: processing at around 65°C tends to preserve andrographolide content better than lower temperatures.³

How It Works in the Body

Andrographolide’s main claim to fame is its ability to dial down inflammation. It does this by interfering with NF-κB, a protein complex that acts as a master switch for inflammatory gene activation. In lab and animal studies, andrographolide blocks NF-κB signaling, which in turn reduces the release of inflammatory chemicals like certain interleukins and prostaglandins.⁴ This same mechanism has been observed in brain tissue, joint tissue, and gut tissue across various animal models, making it a broadly acting anti-inflammatory compound rather than one that targets a single organ system.

Beyond tamping down inflammation, andrographolide appears to modulate the immune system in more subtle ways. It can influence the behavior of macrophages (the immune cells that engulf pathogens) and shape antibody production.⁵ In a small open-label study of healthy adults, a standardized extract increased T helper cells and shifted the balance of certain signaling molecules involved in immune coordination over 30 days. The distinction between “boosting” and “modulating” immunity matters here: the compound doesn’t simply crank everything up; it seems to adjust immune responses in multiple directions depending on the context.

Upper Respiratory Infections

The strongest clinical evidence for andrographis sits squarely in the territory of colds and other acute respiratory infections. This is where the herb has been tested most rigorously, with multiple randomized controlled trials and at least two systematic reviews synthesizing the data. A meta-analysis pooling results from several trials found that andrographis, compared to placebo, reduced cough and sore throat symptoms and shortened the time to getting better.⁶ An earlier systematic review of randomized trials similarly found that andrographis preparations, both alone and in fixed combinations with other herbs, outperformed placebo on symptom severity scores for uncomplicated upper respiratory tract infections.⁷

That said, the researchers behind these reviews are careful to note that the overall quality of the included trials was poor. Small sample sizes, inconsistent dosing, and methodological shortcomings are common across this literature. The results are encouraging enough that several Scandinavian and Asian countries have approved andrographis-based cold remedies (Kan Jang is a well-known branded product), but you should not expect it to work like a prescription antiviral. Think of it more as a supplement that may shorten the duration of a cold by a day or so and ease the worst of the symptoms, if you start early.

Gut Inflammation and Ulcerative Colitis

One of the more intriguing clinical applications is in ulcerative colitis, a chronic inflammatory bowel disease. A placebo-controlled trial tested an andrographis extract (HMPL-004) at two doses in patients with mild to moderate disease. At the higher dose of 1,800 mg daily, 60% of patients achieved a clinical response by week 8, compared to 40% on placebo.⁸ A separate trial took the comparison further by pitting the same extract head-to-head against mesalazine (mesalamine), the standard first-line drug for ulcerative colitis. The results showed no significant difference between the two treatments, with similar rates of remission and response by colonoscopy.⁹

These are genuinely interesting findings, and they align with what we know about andrographolide’s anti-inflammatory mechanisms in gut tissue. However, both trials were relatively small, and the extract used (HMPL-004) was a specific, standardized preparation. Whether the random andrographis supplement from a health food store would produce the same results is an open question. Researchers have not yet conducted the larger confirmatory trials needed to make andrographis a standard recommendation in gastroenterology, but it is on the radar as a potential add-on or alternative for patients who cannot tolerate conventional medications.

Joint Pain and Rheumatoid Arthritis

A small randomized, placebo-controlled trial tested an andrographis composition in people with rheumatoid arthritis and found meaningful reductions in tender and swollen joints over the study period. Participants also showed improvements on standard quality-of-life questionnaires and reductions in rheumatoid factor and certain immunoglobulins, markers that track with disease activity.¹⁰ The authors themselves describe the herb as a potential “natural complement” rather than a replacement for standard treatment, and they stress the need for larger, longer trials. If you have RA, this is worth knowing about but not worth changing your treatment plan over without discussing it with your rheumatologist.

Liver Protection, With a Caveat

Andrographolide has shown hepatoprotective effects in various animal models of liver damage, including injury from toxins and high-fat diets. Research suggests it can reduce fat accumulation in the liver and dampen the inflammatory signaling that drives non-alcoholic steatohepatitis (fatty liver disease that progresses to inflammation).¹¹ This liver-protective narrative is a big part of the herb’s marketing in traditional and integrative medicine circles.

But here is where it gets complicated. A cross-sectional study of patients in Thailand who used andrographis during the COVID-19 pandemic found that those who took the herb had slightly but statistically significant elevations in liver enzymes (ALT and AST) compared to non-users. After adjusting for other factors like body weight and pre-existing fatty liver disease, andrographis use was independently associated with about 60% higher odds of experiencing a meaningful ALT increase.¹² The elevations were mostly mild, but they are a signal worth taking seriously, especially for people with existing liver conditions or those taking the herb at high doses for extended periods. The lesson is familiar in herbal medicine: something can be liver-protective under certain conditions (acute toxic injury, lab models) and still cause liver enzyme elevations in other real-world contexts.

Preclinical Cancer Research

Andrographolide has attracted attention in cancer biology for its ability to trigger programmed cell death (apoptosis) in various tumor cell lines. In lab studies, it has shown activity against cancer cells from the pancreas, stomach, cervix, and brain, working through mechanisms that shut down survival pathways cancer cells depend on.¹³ ¹⁴ One study in cervical cancer cell lines found that andrographolide suppressed the NF-κB and COX-2 pathways in a dose-dependent manner while activating a tumor suppressor gene called PTEN.¹⁵

Before anyone gets too excited, a critical distinction applies: all of this work is preclinical, meaning it was done in cell cultures and animal models, not in human cancer patients. Many compounds that kill cancer cells in a petri dish fail spectacularly in human trials. No one should take andrographis as a cancer treatment, and no clinical trial has yet demonstrated benefit in human oncology. The research is at the stage of understanding what the compound does mechanistically and whether it warrants further development, not at the stage of therapeutic recommendation.

Neuroprotective Effects in Animal Models

Animal research on andrographolide’s effects on the brain has generated some compelling results, particularly in stroke models. When given to rats after permanent blockage of a major brain artery, andrographolide at a dose of 0.1 mg per kilogram reduced brain damage volume by roughly half and improved neurological function. The benefit appeared to come from the same anti-inflammatory mechanisms seen elsewhere: reduced microglial activation and lower levels of inflammatory cytokines in the affected brain tissue.¹⁶ Similar protective effects have been observed in mouse models of ischemia-reperfusion injury, the damage that occurs when blood flow returns to oxygen-starved brain tissue.¹⁷

In Alzheimer’s disease models, andrographolide has been reported to reduce the aggregation of amyloid-beta protein and protect synapses from deterioration.¹⁸ Again, these are animal findings only. The leap from rodent stroke models to human stroke treatment is enormous, and many neuroprotective compounds that worked beautifully in rats have failed in clinical trials. This line of research is worth watching but years away from clinical application at best.

Side Effects and Safety Profile

A review of safety data across multiple clinical studies found that most reported adverse reactions were mild and primarily gastrointestinal: nausea, diarrhea, vomiting, abdominal pain, and bloating. Skin reactions like rash and itching also came up occasionally. Out of 165 adverse events catalogued across the reviewed studies, the overwhelming majority were graded as the mildest possible severity, with only a handful reaching moderate grade.¹⁹

So for short-term use at standard doses, andrographis appears reasonably safe for most people. The more concerning signals emerge with longer use or in specific populations, particularly the liver enzyme elevations discussed earlier and the reproductive effects covered below.

The Fertility Question

One of the more unusual aspects of andrographis is its traditional use as a contraceptive in some cultures, and animal studies lend some credibility to that folk use. An older study in female mice found that feeding them dried andrographis powder for six weeks resulted in complete infertility when mated with proven-fertile males, while 95% of control females became pregnant.²⁰ Another animal study in female rats showed a dose-duration relationship: infertility rates climbed from about a third at four weeks to 100% at eight weeks of exposure, accompanied by declining levels of reproductive hormones.²¹

On the male side, the picture looks less alarming. A study in male rats given a standardized extract at doses up to 1,000 mg per kilogram per day found no effect on testosterone, sperm count, sperm motility, or actual fertility outcomes.²² The disconnect between male and female reproductive effects in animals is not fully understood, and human fertility studies are essentially absent. Still, the consistent female anti-fertility findings in rodents are enough to warrant a clear precaution: if you are trying to conceive or are pregnant, avoid andrographis until more is known.

Drug Interactions

The most clinically relevant drug interaction identified so far is with warfarin, the common blood thinner. A rat study found that giving andrographolide alongside warfarin roughly doubled warfarin’s exposure in the bloodstream and extended its half-life considerably. The likely mechanism involves andrographolide inhibiting the liver enzymes (CYP3A4 and CYP2C9) responsible for breaking down warfarin.²³ For a drug with as narrow a therapeutic window as warfarin, where too much can cause dangerous bleeding, this is not a minor concern. If you take warfarin or other blood thinners, steer clear of andrographis supplements.

The same enzyme inhibition that affects warfarin could theoretically alter the metabolism of other drugs processed through the same pathways, though specific interaction studies for most medications have not been done. As a general rule, if you take any drug with a narrow safety margin, discuss andrographis with your prescriber before adding it.

Absorption and Bioavailability

When you swallow an andrographis supplement, the andrographolide gets absorbed quickly: blood levels peak within about one to two hours after a standard oral dose. In human volunteers, a single therapeutic dose of the branded product Kan Jang (delivering 20 mg of andrographolide) reached peak plasma levels within 1.5 to 2 hours, with a half-life of about 6.6 hours.²⁴ One important detail: bioavailability drops substantially at higher doses. In rats, a tenfold increase in dose led to a fourfold decrease in bioavailability, suggesting the body’s ability to absorb andrographolide saturates at a certain threshold. More is not necessarily better, and very high doses may simply be wasted.

Researchers have experimented with ways to improve absorption. A study in dogs found that combining andrographis with piperine (the compound that makes black pepper pungent) and a solubilizing agent nearly doubled the relative oral bioavailability of andrographolide compared to taking the herb alone.²⁵ Some supplement manufacturers have already incorporated piperine into their formulations based on this principle, though human pharmacokinetic studies confirming the effect are still needed.

Supplement Quality Is a Real Problem

Here is something that rarely makes it into the marketing copy: a detailed phytochemical analysis of commercial andrographis supplements found that more than a quarter of tested products failed to meet pharmacopeia standards.²⁶ The actual andrographolide content in dietary supplements varied enormously, from zero to 278 mg per serving, compared to 0.4 to 23 mg per gram in raw plant material. Some products contained far less of the active compound than their labels claimed, while others contained far more. This kind of inconsistency is a persistent issue across the herbal supplement market, but it is particularly relevant for andrographis given the dose-dependent absorption ceiling and the potential for drug interactions at high exposures.

Adding to the inconsistency, the quality standards set by different countries’ pharmacopeias do not fully agree on testing methods, fingerprint profiles, or required lactone content for andrographis products.²⁷ What passes muster under the Thai pharmacopeia may not satisfy the European one, and vice versa. For consumers, the practical takeaway is to look for products standardized to a stated andrographolide content and ideally tested by a third-party lab, since the label on its own is not a reliable guarantee.

Antiviral Interest and the COVID-19 Chapter

Andrographolide and its derivatives have shown activity against several viruses in lab studies, and unsurprisingly, the herb received a surge of attention during the COVID-19 pandemic.²⁸ Thailand’s national health authorities actually approved andrographis capsules as a treatment option for mild COVID-19 symptoms, which led to a wave of self-medication. This real-world use is what generated the liver enzyme data discussed earlier, since researchers were able to study what happened when large numbers of people with gastrointestinal symptoms started taking the herb outside of controlled trial conditions.

The antiviral evidence remains overwhelmingly preclinical. Lab studies showing that a compound can interfere with viral replication in cell cultures do not translate automatically to clinical benefit. No large, well-designed clinical trial has demonstrated that andrographis treats or prevents COVID-19 or any other viral infection more effectively than standard care, beyond the modest effects on cold symptoms documented in the respiratory infection reviews. The pandemic episode is a useful reminder that traditional medicines with real pharmacological activity still need rigorous clinical testing before they can be recommended with confidence for new indications.

Growing Conditions and Andrographolide Content

For readers interested in the supply side, how andrographis is cultivated has a meaningful impact on what ends up in your supplement. Research under controlled growing conditions found that planting density and harvest timing both affect andrographolide accumulation. Harvesting at the flowering stage, roughly 90 days after transplanting, appears to maximize the compound’s concentration. Too-dense planting reduces photosynthetic rates and ultimately lowers yield per plant, though moderate density provides the best overall balance of leaf production and andrographolide content per unit area.²⁹ These agronomic variables contribute to the wide variation in raw material quality and help explain why two andrographis supplements from different sources can contain dramatically different amounts of the active compound.